Wang, Nan
Zhang, Li
Ying, Qi
Song, Zhentao
Lu, Aiping
Treumann, Achim
Liu, Zhaojian
Sun, Tao
Ding, Zhiyong
Article History
Received: 2 April 2022
Accepted: 19 December 2022
First Online: 26 December 2022
Competing interests
: Fynn Biotechnologies holds commercial interests on AGLyse protein extraction buffer (the commercial name of related RPPA extraction methods provided in Supplementary tables) and has an associated patent (ZL 2017 1 1323182.6) and offers RPPA screening as a commercial service Dr Achim Treumann has acted in the past as a consultant for Fynn Biotechnologies.